Table 2. Results of in vitro enzyme inhibition assay tests.

	COX-1 [%]						COX-2 [%]
ID	1		10		100		1		10		100
	6±	2.0	9±	4.2	15±	1.6	19±	2.1	23±	†	17±	3.2
	−3±	3.5	−5±	1.0	26±	23.5	14±	9.7	9±	2.2	6±	1.6
	8±	1.3	12±	3.5	10±	5.1	19±	0.7	10±	1.9	14±	0.1
	6±	10.7	−6±	3.8	−2±	2.8	3±	3.2	3±	7.4	−1±	9.9
	7±	3.9	31±	3.8	72±	4.5	27±	8.1	27±	1.4	38±	3.7
	16±	4.7	18±	9.3	15±	1.6	19±	†	0±	10.0	12±	2.9
	2±	4.5	4±	8.4	7±	†	20±	9.4	13±	8.8	15±	0.3
	2±	4.5	29±	26.8	16±	8.0	14±	2.6	8±	2.1	11±	6.2
	6±	16.8	46±	6.1	89±	1.0	9±	0.7	24±	7.6	38±	3.1
	−7±	1.6	−10±	8.5	7±	2.8	2±	5.5	−2±	2.7	−1±	3.7
	11±	12.6	5±	0.6	1±	1.5	5±	2.9	4±	4.2	0±	1.1
	18±	4.0	8±	4.5	14±	1.5	15±	0.1	15±	7.5	19±	2.2

Primed () compounds are shown in Fig. 8, starred () compounds are shown in Fig. 9. Discussed compounds are shown in bold face.

^†For these three measurements, high standard deviations were observed. This could be due to solubility problems, impurities, protein degradation, or other unspecific effects. The corresponding measurements should be treated carefully.